Publications by authors named "Yuji Negoro"

Claim this Profile
C
Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B).
Satoshi Kobayashi, Kohei Nakachi, Kouji Yamamoto, Makoto Ueno, Yuta Maruki, Yuji Negoro

J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor DNA Profiling Reveals Genomic Evolution in Recurrent Gastric or Gastroesophageal Junction Cancer.
Ryohei Kawabata, Hiroyuki Takeda, Atsushi Ishiguro, Shinichi Nishina, Masazumi Takahashi, Yuji Negoro

Mol Diagn Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.
Hiroshi Imaoka, Masafumi Ikeda, Satoshi Kobayashi, Akihiro Ohba, Masayuki Ueno, Yuji Negoro

J Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting.
Hiroshi Imaoka, Masafumi Ikeda, Satoshi Kobayashi, Akihiro Ohba, Masayuki Ueno, Yuji Negoro

J Gastroenterol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase two trial evaluating FOLFIRI plus aflibercept after failure of FOLFOXIRI plus bevacizumab in patients with unresectable metastatic colorectal cancer.
Koji Ando, Hironaga Satake, Mototsugu Shimokawa, Hisateru Yasui, Yuji Negoro

Int J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E and Non-V600E Mutations in RAS Wild-Type Metastatic Colorectal Cancer: Prognostic and Therapeutic Insights from a Nationwide, Multicenter, Observational Study (J-BROS).
Hiroya Taniguchi, Kay Uehara, Toshiaki Ishikawa, Osamu Okochi, Naoya Akazawa, Yuji Negoro

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09).
Ryohei Kawabata, Naoki Izawa, Takahisa Suzuki, Yoshio Nagahisa, Kazuhiro Nishikawa, Yuji Negoro

Target Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Masahiko Aoki, Shigenori Kadowaki, Naoki Takahashi, Takeshi Suzuki, Kotoe Oshima, Yuji Negoro

Gastric Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer.
Kensei Yamaguchi, Keiko Minashi, Daisuke Sakai, Tomohiro Nishina, Yasushi Omuro, Yuji Negoro

Cancer Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years.
Toshikazu Moriwaki, Tomohiro Nishina, Yoshinori Sakai, Yoshiyuki Yamamoto, Mitsuo Shimada, Yuji Negoro

Jpn J Clin Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment.
Hiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, Atsuo Takashima, Yosuke Kumekawa, Yuji Negoro

Front Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapy.
Makoto Ueno, Chigusa Morizane, Masayuki Furukawa, Daisuke Sakai, Yoshito Komatsu, Yuji Negoro

Cancer Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.
Toshiki Masuishi, Akihito Tsuji, Masahito Kotaka, Masato Nakamura, Mitsugu Kochi, Yuji Negoro

Br J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of pembrolizumab in combination with S-1 plus oxaliplatin as a first-line treatment in patients with advanced gastric/gastroesophageal junction cancer: Cohort 1 data from the KEYNOTE-659 phase IIb study.
Akihito Kawazoe, Kensei Yamaguchi, Hisateru Yasui, Yuji Negoro, Mizutomo Azuma

Eur J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study).
Nobuaki Suzuki, Shoichi Hazama, Takeshi Nagasaka, Hiroaki Tanioka, Yasuo Iwamoto, Yuji Negoro

Int J Clin Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic cancer arising from the remnant pancreas after pancreatectomy: a multicenter retrospective study by the Kyushu Study Group of Clinical Cancer.
Daisuke Hashimoto, Kota Arima, Shigeki Nakagawa, Yuji Negoro, Toshihiko Hirata

J Gastroenterol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.
Yu Sunakawa, Dongyun Yang, Shu Cao, Wu Zhang, Miriana Moran, Yuji Negoro

Clin Colorectal Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer.
Yu Sunakawa, Kaoru Mogushi, Heinz-Josef Lenz, Wu Zhang, Akihito Tsuji, Yuji Negoro

Mol Cancer Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study.
Akitaka Makiyama, Kenji Kunieda, Masaaki Noguchi, Takeshi Kajiwara, Takao Tamura, Yuji Negoro

Gastric Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma.
Tatsuaki Sumiyoshi, Yasuo Shima, Takehiro Okabayashi, Yuji Negoro, Yasuhiro Shimada

World J Surg· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tc-GSA SPECT/CT fusion imaging for hepatectomy candidates with extremely deteriorated ICG value.
Tatsuaki Sumiyoshi, Takehiro Okabayashi, Yuji Negoro, Yasuhiro Hata, Yoshihiro Noda

Jpn J Radiol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).
Yuji Miura, Yasutaka Sukawa, Shuichi Hironaka, Misuzu Mori, Kazuhiro Nishikawa, Yuji Negoro

Gastric Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel utility of Tc-GSA SPECT/CT fusion imaging: detection of inadequate portal vein embolization.
Tatsuaki Sumiyoshi, Yasuo Shima, Takehiro Okabayashi, Yasuhiro Hata, Yoshihiro Noda, Yuji Negoro

Jpn J Radiol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer.
Yu Sunakawa, Akihito Tsuji, Tadamichi Denda, Yoshihiko Segawa, Yuji Negoro

Target Oncol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidetector CT in detection of troublesome posterior sectoral hepatic duct communicating with cystic duct.
Sumiyoshi Tatsuaki, Shima Yasuo, Okabayashi Takehiro, Hata Yasuhiro, Noda Yoshihiro, Negoro Yuji

Br J Radiol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis